Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: The role of NMDA and group I metabotropic glutamate receptors

Acta Neurobiologiae Experimentalis

Volumn 66, Issue 4, 2006, Pages 301-309

  Zieminska, Elzbieta ^a   Lazarewicz, Jerzy W ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Amantadine; Cerebellar granule cells; Excitotoxicity; Homocysteine; Memantine; Neuroprotection

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 4 CARBOXY 2 METHYLPHENYLGLYCINE; AMANTADINE; DIZOCILPINE; HOMOCYSTEINE; MEMANTINE; METABOTROPIC RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CELL VIABILITY; CEREBELLUM; CONTROLLED STUDY; DRUG POTENTIATION; EXCITOTOXICITY; NERVE CELL LESION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; HOMOCYSTINE; NEURONS; NEUROTOXINS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 33846297362     PISSN: 00651400     EISSN: 00651400     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15: 961-973.
2. Benz B, Grima G, Do KQ (2004) Glutamate-induced homocysteic acid release from astrocytes: Possible implication in glia-neuron signaling. Neuroscience 124: 377-386.
3. Bissoli L, Di Francesco V, Ballarin A, Mandragona R, Trespidi R, Brocco G, Caruso B, Bosello O, Zamboni M (2002) Effect of vegetarian diet on homocysteine levels. Ann Nutr Metab 46: 73-79.
4. Blandini F, Fancellu R, Martignoni E, Mangiagalli A, Pacchetti C, Samuele A, Nappi G (2001) Plasma homocysteine and 1-dopa metabolism in patients with Parkinson disease. Clin Chem 47: 1102-1104.
5. Blanpied TA, Boeckman FA, Aizenman E, Johnson JW (1997) Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol 77: 309-323.
6. Blanpied TA, Clarke RJ, Johnson JW (2005) Amantadine inhibits NMDA receptors by accelerating channel closure during channel block. J Neurosci 25: 3312-3322.
7. Chen HS, Lipton SA (2006) The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem 97: 1611-1626.
8. Choi DW (1985) Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58: 293-297.
9. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM (1998) Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55: 1449-1455.
10. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci Biobehav Rev 21: 455-468.
11. De Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E (2005) Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications 19: 42-46.
12. Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease. J Neurochem 80: 101-110.
13. Gallo V, Suergiu R, Giovannini C, Levi G (1987) Glutamate receptor subtypes in cultured cerebellar neurons: Modulation of glutamate and gamma-aminobutyric acid release. J Neurochem 49: 1801-1809.
14. Gasparini F, Kuhn R, Pin JP (2002) Allosteric modulators of group I metabotropic glutamate receptors: Novel subtype-selective ligands and therapeutic perspectives. Curr Opin Pharmacol 2: 43-49.
15. Godfrey PS, Toone BK, Carney MW, Flynn TG, Bottiglieri T, Laundy M, Chanarin I, Reynolds EH (1990) Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336: 392-395.
16. Guerra-Shinohara EM, Paiva AA, Rondo PH, Yamasaki K, Terzi CA, D'Almeida V (2002) Relationship between total homocysteine and folate levels in pregnant women and their newborn babies according to maternal serum levels of vitamin B12. BJOG 109: 784-791.
17. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354: 407-413.
18. Huang G, Dragan M, Freeman D, Wilson JX (2005) Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons. Glia 51: 47-55.
19. Hultberg B, Andersson A, Sterner G (1993) Plasma homocysteine in renal failure. Clin Nephrol 40: 230-235.
20. Jakubowski H (2004) Molecular basis of homocysteine toxicity in humans. Cell Mol Life Sci 61: 470-487.
21. Kim WK, Pae YS (1996) Involvement of N-methyl-d-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett 216: 117-120.
22. Kishi T, Tanaka Y, Ueda K (2000) Evidence for hypomethylation in two children with acute lymphoblastic leukemia and leukoencephalopathy. Cancer 89: 925-931.
23. Kishi S, Griener J, Cheng C, Das S, Cook EH, Pei D, Hudson M, Rubnitz J, Sandlund JT, Pui CH, Relling MV (2003) Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia. J Clin Oncol 21: 3084-3091.
24. Kristal BS, Dubinsky JM (1997) Mitochondrial permeability transition in the central nervous system: induction by calcium cycling-dependent and -independent pathways. J Neurochem 69: 524-538.
25. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20: 6920-6926.
26. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22: 1752-1762.
27. Lazarewicz JW, Ziembowicz A, Matyja E, Stafiej A, Zieminska E (2003) Homocysteine-evoked 45Ca release in the rabbit hippocampus is mediated by both NMDA and group I metabotropic glutamate receptors: In vivo microdialysis study. Neurochem Res 28: 259-269.
28. Lipton SA (2005) The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: Low-affinity, uncompetitive antagonism. Curr Alzheimer Res 2: 155-165.
29. Lipton SA, Kim WK, Choi YB, Kumar S, D'Emilia DM, Rayudu PV, Arnelle DR, Stamler JS (1997) Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 94: 5923-5928.
30. Madonna P, de Stefano V, Coppola A, Cirillo F, Cerbone AM, Orefice G, Di Minno G (2002) Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 33: 51-56.
31. Marini AM, Ueda Y, June CH (1999) Intracellular survival pathways against glutamate receptor agonist excitotoxicity in cultured neurons. Intracellular calcium responses. Ann N Y Acad Sci 890: 421-437.
32. Maruszczak A, Gaweda-Walerych K, Soltyszewski I, Zekanowski C (2006) Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases. Acta Neurobiol Exp (Wars) 66: 153-176.
33. Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26: 137-146.
34. Morris MS (2003) Homocysteine and Alzheimer's disease. Lancet Neurol 2: 425-428.
35. Molloy AM, Weir DG (2001) Homocysteine and the nervous system. In: Homocysteine in Health and Disease (Carmel R, Jacobsen DW, eds). Cambridge University Press, pp.183-197.
36. Parnetti L, Caso V, Santucci A, Corea F, Lanari A, Floridi A, Conte C, Bottiglieri T (2004) Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke. Neurol Sci 25: 13-27.
37. Pniewski J, Chodakowska-Zebrowska M, Wozniak R, Stepien K, Stafiej A (2003) Plasma homocysteine level and the course of ischemic stroke. Acta Neurobiol Exp (Wars) 63: 127-130.
38. Ritzen A, Mathiesen JM, Thomsen C (2005) Molecular pharmacology and therapeutic prospects of metabotropic glutamate receptor allosteric modulators. Basic Clin Pharmacol Toxicol 97: 202-213.
39. Salinska E, Danysz W, Lazarewicz JW (2005) The role of excitotoxicity in neurodegeneration. Folia Neuropathol 43: 322-339.
40. Schousboe A, Drejer J, Hansen GH, Meier E (1985) Cultured neurons as model systems for biochemical and pharmacological studies on receptors for neurotransmitter amino acids. Dev Neurosci 7: 252-262.
41. Scott JM (2001) Modification of hyperhomocysteinemia. In: Homocysteine in Health and Disease (Carmel R, Jacobsen DW, eds). Cambridge University Press, pp. 267-276.
42. Selhub J (1999) Homocysteine metabolism. Ann Rev Nutr 19: 217-246.
43. Selhub J, Miller JW (1992) The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 55: 131-138.
44. Shi Q, Savage JE, Hufeisen SJ, Rauser L, Grajkowska E, Ernsberger P, Wroblewski JT, Nadeau JH, Roth BL (2003) L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists. J Pharmacol Exp Ther 305: 131-142.
45. Slassi A, Isaac M, Edwards L, Minidis A, Wensbo D, Mattsson J, Nilsson K, Raboisson P, McLeod D, Stormann TM, Hammerland LG, Johnson E (2005) Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications. Curr Top Med Chem 5: 897-911.
46. Togawa T, Sengupta S, Chen H, Robinson K, Nonevski I, Majors AK, Jacobsen DW (2000) Mechanisms for the formation of protein-bound homocy steine in human plasma. Biochem Biophys Res Commun 277: 668-674.
47. Ueland P (1995) Homocysteine species as components of plasma redox thiol status. Clin Chem 41: 340-342.
48. Van Aerts LA, Klaasboer HH, Postma NS, Pertijs JC, Copius-Peerboom JH, Eskes TK, Noordhoek J (1993) Stereospecific in vitro embryotoxicity of L-homocysteine in pre- and post-implantation rodent embryos. Toxic In Vitro 7: 743-749.
49. Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 6: 27-36.
50. Yasui K, Kowa H, Nakaso K, Takeshima T, Nakashima K (2000) Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. Neurology 55: 437-440.
51. Yudkoff M (1999) Diseases of amino acid metabolism. In: Basic Neurochemistry; Molecular, Cellular and Medical Aspects (Siegel GJ, ed.). Lippincott Williams & Wilkins, a Wolters Kluwer Company. p. 887-915.
52. Zieminska E, Matyja E, Kozlowska H, Stafiej A, Lazarewicz JW (2006) Excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations. Neurochem Int 48: 491-497.
53. Zieminska E, Stafiej A, Lazarewicz JW (2003) Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones. Neurochem Int 43: 481-492.